Magnus Nylén
Director/Board Member at SELECTIMMUNE PHARMA AB (PUBL)
Profile
Magnus Nylén is currently a Director at Hamlet BioPharma AB, a Director at SelectImmune Pharma AB since 2022, and the Owner of Partner Fondkommission AB since 2013.
He completed his undergraduate degree at Boston University.
Magnus Nylén active positions
| Companies | Position | Start |
|---|---|---|
| SELECTIMMUNE PHARMA AB (PUBL) | Director/Board Member | 23/11/2022 |
| HAMLET PHARMA AB (PUBL) | Director/Board Member | - |
Partner Fondkommission AB
 Partner Fondkommission AB Investment ManagersFinance Partner Fondkommission AB provides financial advisory services. It offers mergers and acquisitions, brokerage, and issuer services. The company was founded in 2007 and is headquartered in Gothenburg, Sweden. | Corporate Officer/Principal | 01/01/2013 |
Training of Magnus Nylén
| Boston University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SELECTIMMUNE PHARMA AB (PUBL) | Health Technology |
| HAMLET PHARMA AB (PUBL) | Health Technology |
| Private companies | 1 |
|---|---|
Partner Fondkommission AB
Partner Fondkommission AB Investment ManagersFinance Partner Fondkommission AB provides financial advisory services. It offers mergers and acquisitions, brokerage, and issuer services. The company was founded in 2007 and is headquartered in Gothenburg, Sweden. | Finance |
- Stock Market
- Insiders
- Magnus Nylén
